← All diseases Metabolism and endocrine system

Systemic amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (28)Meta-analysis (4)Treatment guideline (4)Systematic review (11)Phase 3 study (8)Randomized trial (1)Clinical trial (192)Review article (235)Early study (phase 1 or 2) (17)Case report (283)Laboratory or animal study (21)Commentary or editorial (21) Studies currently recruiting participants only (30)

Filter

Publications and studies (1226)

• Bortezomib combined with autologous stem cell transplantation overcomes cytogenetic abnormalities in AL amyloidosis. (2026/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates. (2026/05/01) ♡
• The cally index as an indicator of inflammatory burden across clinical phases of familial mediterranean fever. (2026/05/01) ♡
• Pulmonary amyloidosis: clinicopathologic spectrum and diagnostic pitfalls in a 12-patient case series. (2026/04/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Unexpected Splenic and Retroperitoneal Uptake on Technetium-99m Pyrophosphate (Tc-99m PYP) Imaging: Expanding the Spectrum of Extracardiac Findings. (2026/04/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Localized Tonsillar Amyloidosis Associated With a Plasma Cell Neoplasm Presenting as an Oropharyngeal Mass: A Diagnostic Challenge. (2026/04/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Rare Trio: Concomitant Bone Marrow Involvement by Smoldering Myeloma and Systemic Mastocytosis with an Associated Hematologic Neoplasm and ALECT-2 Renal Amyloidosis - A Case Report and Literature Review. (2026/04/27) ♡
• Management of major organ involvement in Behçet syndrome: a systematic literature review informing the 2025 update of the EULAR recommendations. (2026/04/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac Perspective on Amyloidosis: Appropriate Cardiac Diagnostic Approaches Following Histological Amyloid Detection in Tendinopathies. (2026/04/01) ♡
• A de novo dominant-negative PSMB8 mutation causes severe CANDLE/PRAAS due to arrested proteasome biogenesis. (2026/04/01) ♡
• Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm. (2026/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnosis of Amyloidosis in Hand and Plastic Surgery Patients: Optimal Tissue Selection and Examination Methods for Early Detection. (2026/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [ATTR Amyloidosis for Hand Surgeons: A Hidden, Treatable Systemic Disease]. (2026/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A rare cause of persistent cholestatic jaundice: gallbladder amyloidosis. (2026/04/01) ♡
• Diagnostic Yield of Abdominal Wall Fat Pad Biopsy for Systemic Amyloidosis in a Low-Prevalence Referral Cohort. (2026/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Crescentic Glomerulonephritis in a Patient With AL Amyloidosis: A Case Report. (2026/03/28) ♡
• Management of mucocutaneous and joint involvement of Behçet's syndrome: a systematic literature review informing the 2025 update of the EULAR recommendations. (2026/03/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treating the Patient, Not Only the Amyloid: Symptomatic Management in Transthyretin Amyloidosis. (2026/03/13) ♡
• Adalimumab for AA Amyloidosis Secondary to Severe Hidradenitis Suppurativa. (2026/03/12) ♡
• Protective Effect of Paeoniae Radix Alba Carbonisata on Hepatic Amyloidosis by Regulating Calcium Homeostasis. (2026/03/11) ♡
• Bile cast nephropathy presenting as acute kidney injury in systemic light chain amyloidosis with severe hepatic involvement. (2026/03/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis. (2026/03/01) ♡
• An Accelerated Sonication-Assisted Preparation method for mass spectrometry-based identification of subtype specific amyloidogenic proteins in fat aspirates. (2026/03/01) ♡
• Abdominal Fat Pad Fine-Needle Aspiration for the Diagnosis of Cardiac Amyloidosis: A Technical Note With Illustrative Images. (2026/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Avoiding serious treatment-emergent adverse events in Waldenström macroglobulinemia patients. (2026/03/01) ♡
• Novel noninvasive parameters for diagnosis of liver involvement in patients with systemic AL amyloidosis. (2026/02/01) ♡
• A new digenic inheritance of proteasome-associated autoinflammatory syndrome involving the PSMA6 gene. (2026/02/01) ♡
• New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System. (2026/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of Skin Biopsy Techniques for the Diagnosis of Systemic Amyloidosis. (2026/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Systemic light chain cardiac amyloidosis with atrioventricular block. (2026/01/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A rare presentation of massive hepatomegaly secondary to amyloidosis. (2026/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The Real-World Safety and Efficacy of Bispecific T-Cell Engager Therapy in Systemic AL Amyloidosis. (2026/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in management of systemic AL amyloidosis. (2026/01/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Diet-related poor nutritional status as a major challenge in the treatment of patients with amyloidosis: A systematic review. (2026/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer (2026-08-10) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004) (2026-08-07) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis (2026-07-28) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis (2026-07-24) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis (2026-07-23) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of NXC-201 Compared With Daratumumab With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) in Newly Diagnosed Systemic AL Amyloidosis (2026-07-16) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis (AMYLOCARP) (2026-07-16) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis (2026-07-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hungarian National Systemic Amyloidosis Registry (2026-07-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Optimize First-line Treatment for AL Amyloidosis With t (11; 14) (2026-07-07) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification (2026-07-07) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Registry of Older Patients With Cancer (2026-06-29) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) (2026-06-22) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant (2026-06-22) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis (2026-06-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging (2026-06-03) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.